UroToday.com· @urotoday · X·· 2 天前评分45
正文 · 机器翻译
骨转移占主导的 #mCRPC 接受 Radium-223 ± Olaparib 治疗期间的纵向 ctDNA 肿瘤分数：COMRADE 2 期试验结果。由 @DrRanaMcKay @UCSanDiego 报告。#ESMO26 文字报道由 @rksayyid @UAUrology 撰写 > https://bit.ly/4eAzxVR #ProstateCancer #PrecisionOncology @myESMO
64 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
LBA37按 Proffered paper: Gynaecological cancers 对上
Durvalumab (D) plus carboplatin/paclitaxel (CP) followed by D with or without olaparib (O) in advanced/recurrent endometrial cancer (a/rEC): Interim overall survival (OS) and safety from the randomised phase 3 DUO-E/GOG-3041/ENGOT-EN10 stud
https://esmocongress.esmo.org来源：UroToday.com · x.com